The specialist integrated CDMO

Browser not supported

Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:

Search

      
          View 
        
      Event
    
      IPAC-RS FDA Roundtable
    
        Date:
        
            2020/11/02
                      
        Location:
        online
      
      View

Press Release / Mar 17, 2021
Hovione completes its Phase 2 clinical trial of the first minocycline ophthalmicShowing promise in Dry Eye Disease associated with Inflamed Meibomian Gland Dysfunction

      View

Press Release / Sep 20, 2019
Hovione announces successful end-of-phase 2 meeting with the FDA and  outlines phase 3 program for minocycline topical gelHovione announced details of its planned MARS-2 and MARS-3 (Minocycline Against Rosacea Study) Phase 3 development program for the treatment of moderate to severe inflammatory rosacea.

Browser not supported

Search

Types

Press Room

Categories

IPAC-RS FDA Roundtable

Hovione completes its Phase 2 clinical trial of the first minocycline ophthalmic

Hovione announces successful end-of-phase 2 meeting with the FDA and outlines phase 3 program for minocycline topical gel